Phlebitis Clinical Trial
Official title:
Investigation of the Effect of Nigella Sativa Oil and Sesame Oil in Preventing Phlebitis
Phlebitis is an inflammatory reaction of the venous system and surrounding tissues that may be associated with mechanical, chemical or infectious microorganisms; It is the most common complication of intravenous injection. Symptoms of phlebitis; local pain, swelling, warmth, erythema, tenderness; prominent redness and palpable firmness and purulent discharge along the vascular access. Phlebitis is the most important peripheral intravenous catheter-related complication and is seen in 0.1%- 63.3% of patients with peripheral intravenous catheters. Intravenous amiodarone is an important treatment for arrhythmias. However, peripheral infusion causes direct irritation of the vessel walls. Intravenous amiodarone is one of the most widely used antiarrhythmics for the treatment of atrial fibrillation with rapid ventricular response. However, peripheral infusion of amiodarone usually causes pain during the infusion followed by phlebitis. Peripheral intravenous infusion of amiodarone associated with phlebitis is common in clinical practice, with an incidence of 5% to 65%. Herbal treatment is a popular method in recent years In recent studies to prevent phlebitis, it has been determined that topical application of sesame oil and black cumin oil is effective in preventing phlebitis. Sesame oil has antioxidant, anti-inflammatory and antibacterial properties and contains several lignans such as sesamin and sesaminol that inhibit inflammation, including interleukin 8 and endothelin 1. The therapeutic properties of black seed oil are due to the presence of phenolic compounds, especially thymoquinone. The anti-inflammatory mechanism of action of black seed oil occurs by inhibiting cyclo-oxygenase and 5-lipoxygenase pathways and preventing the production of thromboxane B2 and leukotriene B4. There is no study in the literature comparing the effects of sesame oil and black cumin oil to prevent phlebitis.
Status | Recruiting |
Enrollment | 108 |
Est. completion date | September 1, 2024 |
Est. primary completion date | August 25, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - 18 years and over, - IV amiodarone treatment was started, - PIC applied to the cephalic or basilic vein, - Number 20 catheter is preferred in PIC application, - At least primary school graduate and can speak Turkish, - Patients who voluntarily agree to participate in the study will be included in the study. Exclusion Criteria: - Diagnosed with active phlebitis, - Having a diagnosis of mental illness or communication problems, - Hearing and vision problems, - Skin integrity is impaired, - Having a body temperature above 38.5 CÂș, - Stating that he is allergic to sesame oil and black cumin oil, - Receiving irritant medication or liquid other than Amiodarone through the catheter, - Receiving long-term IV therapy from cephalic or basilic veins, - Mastectomy surgery, fistula, - who have been diagnosed with SVO, |
Country | Name | City | State |
---|---|---|---|
Turkey | Kütahya Health Sciences University Training and Research Hospital | Merkez | Kütahya |
Lead Sponsor | Collaborator |
---|---|
Kutahya Health Sciences University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | visual infusion phlebitis scale | The scale has Turkish validity and durability.No change is expected in the Visual Infusion Phlebitis Scale score (2 points and above) in the sesame oil administration group (36 individual) | Phlebitis formation is not expected during the follow-up period (72 hours) in the nigella sativa oil applied group. | |
Primary | visual infusion phlebitis scale | The scale has Turkish validity and durability.No change is expected in the Visual Infusion Phlebitis Scale score (2 points and above) in the nigella sativa oil administration group (36 individual) | Phlebitis formation is not expected during the follow-up period (72 hours) in the nigella sativa oil applied group. | |
Primary | visual infusion phlebitis scale | The scale has Turkish validity and durability.Changes in the Visual Infusion Phlebitis Scale score (2 points and above) are expected in the control group (36 individuals). | Phlebitis formation is expected during the follow-up period (72 hours) in the control group. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00989599 -
Use of Chamomilla Recutita in Phlebitis
|
Phase 3 | |
Completed |
NCT05714137 -
Reducing the Risk of Phlebitis From Peripheral Venous Catheter
|
N/A | |
Completed |
NCT02568670 -
Removal Peripheral Intravenous Catheters According to Clinical Signs or Every 96 Hours: A Non Inferiority Study
|
N/A | |
Completed |
NCT00670540 -
Epidemiology of Thromboembolism Disease: A Cohort Study
|
N/A | |
Completed |
NCT03193827 -
In-line Filtration Reduces Postoperative Phlebitis.
|
N/A | |
Completed |
NCT04569474 -
Peripheral IV Dressing and Phlebitis in Patients From Amazon
|
N/A | |
Completed |
NCT01943006 -
Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis
|
Phase 3 | |
Terminated |
NCT00418470 -
Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People
|
Phase 4 | |
Active, not recruiting |
NCT00103636 -
Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change
|
Phase 2/Phase 3 | |
Completed |
NCT05058053 -
THE EFFECT OF COLD APPLICATION ON THE DEVELOPMENT OF PHLEBITIS IN PATIENTS RECEIVING INTRAVENOUS AMIODARONE TREATMENT.
|
N/A | |
Recruiting |
NCT06375850 -
Effects of Topical Sesame Oil in the Prevention of Peripheral Venous Catheter Phlebitis: Clinical Trial.
|
N/A | |
Completed |
NCT01131754 -
Heparin 100U/L for Prevention of PVC Complications
|
Phase 3 | |
Not yet recruiting |
NCT05870449 -
The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications
|
N/A | |
Suspended |
NCT01794767 -
Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children
|
Phase 4 | |
Completed |
NCT04817020 -
Effect of Skin Antisepsis on Phlebitis
|
N/A | |
Completed |
NCT05226312 -
Phlebitis Care and Warm Wet Application
|
N/A | |
Terminated |
NCT04218643 -
Ultrasound-guided Peripheral Intravenous Catheter Insertion Technique
|
N/A | |
Not yet recruiting |
NCT04685031 -
Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis
|
Phase 1/Phase 2 | |
Completed |
NCT04127149 -
Evaluation of Ultra-portable Ultrasound in General Practice
|
N/A | |
Completed |
NCT06216522 -
The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults
|
N/A |